Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following ...

In urothelial bladder cancer, increased T cell infiltration has been correlated with longer patient survival. Previous clinical studies with an FGFR inhibitor, rogaratinib, demonstrated that the ...

CG Oncology stock is up 7% following bladder cancer data released by Johnson & Johnson. Read more here.

AstraZeneca’s Imfinzi recently became the first PD-1/L1 inhibitor to deliver a patient survival win in muscle-invasive ...

Modulating intake of dietary lipids could open up an avenue for treatment. Cancer cells seldom start off stealthy. Quite to the contrary, they announce their presence to the immune system by ...

Identifying the Initial Steps in Colorectal Cancer Formation May 29, 2024 — Research provides new evidence that most colorectal cancers begin with the loss of intestinal stem cells, even before ...

The subtypes investigated in bladder cancer were CK19 ... but the results of a pilot study are encouraging. Detecting cancer cells in the bloodstream is expected to provide great information ...